Innate Pharma (IPHYF)

OTC Markets


Symbol	Exchange	Currency
IPH	Paris	EUR	Real-time
IPHp	BATS Europe	EUR	Delayed
IPHA	NASDAQ	USD	Real-time
IPHYF	OTC Markets	USD	Delayed
IPH	TradeGate	EUR	Delayed

Currency in USD

Disclaimer

2.3000

0.0000(0.00%)

Closed22/08

Fair Value

Unlock Value

Day's Range

2.3000

52 wk Range

1.9301

2.8950

IPHYF Balance Sheet
Featured here, the Balance Sheet for Innate Pharma, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ending dates (either quarterly or annually).

Advanced Balance Sheet

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Current Assets

aa.aa

237.61

173.45

138.26

139.83

148.01

	Cash And Equivalents
	Cash And Equivalents Growth
	Short Term Investments
	Total Receivables
	Accounts Receivable, Total
	Other Receivables
	Inventory
	Prepaid Expenses
	Finance Division Loans and Leases Current
	Finance Division Other Current Assets, Total
	Other Current Assets
	Restricted Cash
	Other Current Assets, Total

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	202.89	136.79	103.76	84.23	70.61
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+33.2%	-32.58%	-24.15%	-18.82%	-16.17%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	15.98	14.85	16.08	17.26	21.85
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	13.14	13.87	13.47	31.02	46.49
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2.82	10.59	0.85	3.08	15.23
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	10.32	3.28	12.63	27.94	31.26
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	5.4	6.83	2.58	4.67	5.69
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.2	1.11	2.36	2.65	3.37
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.2	1.11	2.36	2.65	3.37

Total Assets

aa.aa

401.36

307.42

267.5

207.86

184.19

	Total Assets Growth
	Net Property Plant And Equipment
	Gross Property Plant And Equipment
	Accumulated Depreciation
	Long-term Investments
	Intangible Assets
	Goodwill
	Other Intangibles, Total
	Finance Division Loans and Leases Long-Term
	Other Assets, Total
	Loans Receivable Long-Term
	Accounts Receivable Long-Term
	Deferred Tax Assets Long-Term
	Deferred Charges Long-Term
	Other Long-Term Assets, Total

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-11.05%	-23.4%	-12.99%	-22.29%	-11.39%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	11.67	11.69	10.17	8.54	6.32
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	37.01	38.93	39.88	35.12	9.8
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	96.97	46.29	44.19	1.56	0.42
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	96.97	46.29	44.19	1.56	0.42
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	18.11	37.06	35	22.82	19.65
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1.29	7.09	5.03	8.57	9.01
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	16.83	29.97	29.97	14.25	10.64

Total Current Liabilities

aa.aa

121.82

45.49

79.89

41.34

39.64

	Accounts Payable, Total
	Accrued Expenses, Total
	Short-term Borrowings
	Current Portion of Long-Term Debt / Leases
	Current Portion of Long-Term Debt
	Current Portion of Leases
	Other Current Liabilities, Total
	Current Income Taxes Payable
	Unearned Revenue Current, Total
	Other Current Liabilities

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	27.94	20.73	14.73	13.66	8.56
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2.13	2.14	30.75	2.1	8.94
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1.49	1.37	29.94	1.28	8.45
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.64	0.78	0.8	0.82	0.49
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	91.76	22.62	34.41	25.58	22.14
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	7	8.33	7.46	5.98	7.02
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	70.07	13.13	19.92	16.78	13.51
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	14.68	1.16	7.03	2.82	1.61

Total Liabilities

aa.aa

183.95

151.45

160.06

153.71

132.29

	Total Liabilities Growth
	Long-Term Debt
	Long-Term Leases
	Other Liabilities, Total
	Unearned Revenue Non Current
	Pension & Other Post Retirement Benefits
	Deferred Tax Liability Non Current
	Other Non Current Liabilities

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-35.23%	-17.67%	+5.68%	-3.96%	-13.94%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	14.1	14.19	11.49	38.93	30.61
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2.49	2.76	2.01	1.22	0.35
aa.aa	aa.aa	aa.aa

Popular Searches

Please try another search

Innate Pharma (IPHYF)

IPHYF Balance Sheet
Featured here, the Balance Sheet for Innate Pharma, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ending dates (either quarterly or annually).

Please try another search

Innate Pharma (IPHYF)

IPHYF Balance SheetFeatured here, the Balance Sheet for Innate Pharma, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ending dates (either quarterly or annually).

IPHYF Balance Sheet
Featured here, the Balance Sheet for Innate Pharma, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ending dates (either quarterly or annually).